Moreover, DTIC has been shown to upregulate PD-L1 expression on tumor cells, suggesting that the addition of PD-1/PD-L1 blockade could prevent CAR T cell exhaustion and further prolong remission duration [51]. This evidence concerns the gene CD274 and neoplasm.